The Japanese experience with metabolic imaging in the clinical setting

Journal of Nuclear Cardiology

Volumn 14, Issue 3 SUPPL., 2007, Pages

  Tamaki, Nagara ^a   Morita, Koichi ^a   Kawai, Yuko ^b  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Hokko Memorial Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

15 (4 IODOPHENYL) 3 METHYLPENTADECANOIC ACID I 123; FATTY ACID; FLUORODEOXYGLUCOSE; GLUCOSE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; RADIOPHARMACEUTICAL AGENT; TETROFOSMIN; THALLIUM 201;

ARTICLE; CARDIOMYOPATHY; CORONARY ARTERY DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; FATTY ACID METABOLISM; FATTY ACID OXIDATION; GLUCOSE UTILIZATION; HEART FAILURE; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HEART MUSCLE METABOLISM; HEART PERFUSION; HUMAN; JAPAN; NON INVASIVE PROCEDURE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THORAX PAIN;

CARDIOMYOPATHIES; CRITICAL CARE; FATTY ACIDS; HEART; IODOBENZENES; JAPAN; MYOCARDIUM; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES; RADIOPHARMACEUTICALS;

EID: 34249695831     PISSN: 10713581     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nuclcard.2007.02.012     Document Type: Article

References (57)

1. Liedke A.J. Alterations of carbohydrate and lipid metabolism in the acutely ischemic heart. Prog Cardiovasc Dis 23 (1981) 321-336
2. Schwaiger M., Schelbert H.R., Ellison D., et al. Sustained regional abnormalities in cardiac metabolism after transient ischemia in the chronic dog model. J Am Coll Cardiol 6 (1985) 336-347
3. Schwaiger M., Neese R.A., Araujo L., et al. Sustained nonoxidative glucose utilization and depletion of glycogen in reperfused canine myocardium. J Am Coll Cardiol 13 (1989) 745-754
4. Tamaki N., Morita K., Kuge Y., and Tsukamoto E. The role of fatty acids in cardiac imaging. J Nucl Med 41 (2000) 1525-1534
5. McFalls E.O., Murad B., Liow J.S., et al. Glucose uptake and glycogen levels are increased in pig heart after repetitive ischemia. Am J Physiol Heart Circ Physiol 282 (2002) H205-H211
6. Araujo L.I., McFalls E.O., Lammertsma A.A., Jones T., and Maseri A. Dipyridamole-induced increased glucose uptake in patients with single-vessel coronary artery disease assessed by PET. J Nucl Cardiol 8 (2001) 339-346
7. Knapp Jr. F.F., and Kropp J. Iodine-123-labelled fatty acids for myocardial single-photon emission tomography: current status and future perspectives. Eur J Nucl Med 22 (1995) 361-381
8. Tamaki N., Kawamoto M., Yonekura Y., et al. Regional metabolic abnormality in relation to perfusion and wall motion in patients with myocardial infarction: assessment with emission tomography using an iodinated branched fatty acid. J Nucl Med 33 (1992) 659-667
9. Kawai Y., Tsukamoto E., Nozaki Y., et al. Use of 123I-BMIPP single-photon emission tomography to estimate areas at risk following successful revascularization in patients with acute myocardial infarction. Eur J Nucl Med 25 (1998) 1390-1395
10. Nakajima K., Schimizu K., Taki J., et al. Utility of iodine-123-BMIPP in the diagnosis and follow-up of vasospastic angina. J Nucl Med 36 (1995) 1934-1940
11. Takeishi Y., Fujiwara S., Atsumi H., et al. Iodine-123-BMIPP imaging in unstable angina: a guide for interventional therapy. J Nucl Med 38 (1997) 1407-1411
12. Fujiwara S., Takeishi Y., Atsumi H., et al. Fatty acid metabolic imaging with iodine-123-BMIPP for the diagnosis of coronary artery disease. J Nucl Med 38 (1997) 175-180
13. Tateno M., Tamaki N., Kudoh T., et al. Assessment of fatty acid uptake in patients with ischemic heart disease without myocardial infarction. J Nucl Med 37 (1996) 1981-1985
14. Suzuki A., Takada Y., Nagasaka M., et al. Comparison of resting β-methyl-iodophenyl pentadecanoic acid (BMIPP) and thallium-201 tomography using quantitative polar maps in patients with unstable angina. Jpn Circ J 61 (1997) 133-138
15. 123I-BMIPP scintigraphy for detection of organic coronary stenosis and therapeutic outcome in patients with chest pain. Ann Nucl Med 14 (2000) 187-192
16. Kawai Y., Tsukamoto E., Nozaki Y., Morita K., Sakurai M., and Tamaki N. Significance of reduced uptake of iodinated fatty acid analogue for the evaluation of patients with acute chest pain. J Am Coll Cardiol 38 (2001) 1888-1894
17. Watanabe K., Takahashi T., Miyajima S., et al. Myocardial sympathetic denervation, fatty acid metabolism, and left ventricular wall motion in vasospastic angina. J Nucl Med 43 (2002) 1476-1481
18. Tamaki N., Morita K., and Kuge Y. Fatty acid imaging. In: Zaret B.L., and Beller G.A. (Eds). Clinical nuclear cardiology: state of the art and future directions. 3rd ed. (2004), Mosby, St Louis 559-575
19. Tamaki N., and Morita K. Is BMIPP a sensitive marker for myocardial ischaemic stress?. For. Eur J Nucl Med Mol Imaging 31 (2004) 1031-1033
20. 99mTc-tetrofosmin SPECT and coronary angiography. Circ J 68 (2004) 547-552
21. Hatano T., Chikamori T., Usui Y., Morishima T., Hida S., and Yamashina A. Diagnostic significance of positive I-123 BMIPP despite negative stress Tl-201 myocardial imaging in patients with suspected coronary artery disease. Circ J 70 (2006) 184-189
22. Kageyama H., Morita K., Katoh C., et al. Reduced 123I-BMIPP uptake implies decreased myocardial flow reserve in patients with chronic stable angina. Eur J Nucl Med Mol Imaging 33 (2006) 6-12
23. Nishimura M., Hashimoto T., Kobayashi H., et al. Myocardial scintigraphy using a fatty acid analogue detects coronary artery disease in hemodialysis patients. Kidney Int 66 (2004) 811-819
24. Nishimura M., Murase M., Hashimoto T., et al. Insulin resistance and impaired myocardial fatty acid metabolism in dialysis patients with normal coronary arteries. Kidney Int 69 (2006) 553-559
25. Hasebe N., Moroi M., Nishimura M., et al. B-SAFE, a multicenter cohort study trial to investigate the ability of resting 123I-BMIPP-SPECT to diagnose cardiac disease and predict cardiac events in hemodialysis patients: design and methods. Am Heart J (2007) In press
26. Shinmura K., Tani M., Suganuma Y., et al. Myocardial uptake of iodine-125-labeled 15-(p-iodophenyl)-3-(R,S)-methyl pentadecanoic acid in decreased in chronic diabetic rats with changes in subcellular distribution. Jpn Circ J 62 (1998) 364-370
27. Takeishi Y., Atsumi H., Jufiwara S., Takahashi K., and Tomoike H. Fatty acid metabolic imaging with 123I-BMIPP for a diagnosis of coronary artery disease: application to patients with diabetes mellitus and hyperlipidemia. Nucl Med Commun 17 (1996) 675-680
28. Sakamoto K., Yamasaki Y., Nato S., et al. Mechanism of impaired left ventricular wall motion in the diabetic heart without coronary artery disease. Diabetes Care 21 (1998) 2123-2128
29. Wackers F.J., Brown K.A., Heller G.V., et al. American Society of Nuclear Cardiology position statement on radionuclide imaging in patients with suspected acute ischemic syndromes in the emergency department or chest pain center. J Nucl Cardiol 9 (2002) 246-250
30. Franken P., DeGeeter F., Dendale P., et al. Abnormal free fatty acid uptake in subacute myocardial infarction after coronary thrombolysis: correlation with wall motion and inotropic reserve. J Nucl Med 35 (1994) 1758-1765
31. Furutani Y., Shiigi T., Nakamura Y., et al. Quantification of area at risk in acute myocardial infarction by tomographic imaging. J Nucl Med 38 (1997) 1875-1882
32. Tanaka R., and Nakamura T. Time course evaluation of myocardial perfusion after reperfusion therapy by 99mTc-tetrofosmin SPECT in patients with acute myocardial infarction. J Nucl Med 42 (2001) 1351-1358
33. Taki J., Nakajima K., Matsunari I., et al. Impairment of regional fatty acid uptake in relation to wall motion and thallium-201 uptake in ischaemic but viable myocardium, assessment with iodine-123-labeled beta-methyl-branched fatty acid. Eur J Nucl Med 22 (1995) 1385-1392
34. Kawamoto M., Tamaki N., Yonekura Y., et al. Combined study with I-123 fatty acid and thallium-201 to assess ischemic myocardium. Ann Nucl Med 8 (1994) 47-54
35. Tamaki N., Tadamura E., Kawamoto M., et al. Decreased uptake of iodinated branched fatty acid analog indicates metabolic alterations in ischemic myocardium. J Nucl Med 36 (1995) 1974-1980
36. Hambye A.S.E., Vaerenberg M.M., Dobbeleir A.A., et al. Abnormal BMIPP uptake in chronically dysfunctional myocardial segments: correlation with contractile response to low-dose dobutamine. J Nucl Med 39 (1998) 1845-1850
37. Kumita S., Cho K., Nakajo H., et al. Assessment of contractile response to dobutamine stress by means of ECG-gated myocardial SPECT: comparison with myocardial perfusion and fatty acid metabolism. Ann Nucl Med 19 (2005) 379-386
38. 201Tl uptake in chronically hypoperfused myocardium: histological correlation study. J Nucl Med 41 (2000) 293-296
39. Franken P.R., Dendale P., DeGeeter F., et al. Prediction of functional outcome after myocardial infarction using BMIPP and sestamibi scintigraphy. J Nucl Med 37 (1996) 718-722
40. 201Tl SPECT images. Eur J Nucl Med 23 (1996) 917-923
41. Hashimoto A., Nakata T., Tsuchihashi K., et al. Postischemic functional recovery and BMIPP uptake after primary percutaneous transluminal coronary angioplasty in acute myocardial infarction. Am J Cardiol 77 (1996) 25-30
42. Nakata T., Hashimoto A., Kobayashi H., et al. Outcome significance of thallium-201 and iodine-123-BMIPP perfusion-metabolism mismatch in preinfarction angina. J Nucl Med 38 (1998) 1492-1499
43. Tamaki N., Tadamura E., Kudoh T., et al. Prognostic value of iodine-123 labelled BMIPP fatty acid analogue imaging in patients with myocardial infarction. Eur J Nucl Med 23 (1996) 272-279
44. Nakata T., Kobayashi T., Tamaki N., et al. Prognostic value of impaired myocardial fatty acid uptake in patients with acute myocardial infarction. Nucl Med Commun 21 (2000) 897-906
45. Fukuzawa S., Ozawa S., Shimada K., et al. Prognostic values of perfusion-metabolic mismatch in Tl-201 and BMIPP scintigraphic imaging in patients with chronic coronary artery disease and left ventricular dysfunction undergoing revascularization. Ann Nucl Med 16 (2002) 109-115
46. Nanasato M., Hirayama H., Ando A., et al. Incremental predictive value of myocardial scintigraphy with 123I-BMIPP in patients with acute myocardial infarction treated with primary percutaneous coronary intervention. Eur J Nucl Med Mol Imaging 31 (2004) 1512-1521
47. Matsuki T., Tamaki N., Nakata T., et al. Prognostic value of fatty acid imaging in patients with angina pectoris without prior myocardial infarction: comparison with stress thallium imaging. Eur J Nucl Med Mol Imaging 31 (2004) 1585-1591
48. Chikamori T., Fujita H., Nanasato M., Toba M., and Nishimura T. Prognostic value of I-123 15-(p-iodophenyl)-3-(R,S) methylpentadecanoic acid myocardial imaging in patients with known or suspected coronary artery disease. J Nucl Cardiol 12 (2005) 172-178
49. Kurata C., Tawarahara K., Taguchi T., et al. Myocardial emission computed tomography with iodine-123-labeled beta-methyl-branched fatty acid in patients with hypertrophic cardiomyopathy. J Nucl Med 33 (1992) 6-13
50. Tadamura E., Kudoh T., Hattori N., et al. Impairment of BMIPP uptake precedes abnormalities in oxygen and glucose metabolism in hypertrophic cardiomyopathy. J Nucl Med 39 (1998) 390-396
51. Ohtsuki K., Sugihara H., Kuribayashi T., and Nakagawa M. Impairment of BMIPP accumulation at junction of ventricular septum and left and right ventricular free walls in hypertrophic cardiomyopathy. J Nucl Med 40 (1999) 2007-2013
52. Naruse H., Miyagi J., Arii T., Ohyanagi M., Iwasaki T., and Jinnai K. The relationship between clinical stage, prognosis and myocardial damage in patients with Duchenne-type muscular dystrophy: five-year follow-up study. Ann Nucl Med 18 (2004) 203-208
53. Ito K., Sugihara H., Kinoshita N., Azuma A., and Matsubara H. Assessment of Takotsubo cardiomyopathy (transient left ventricular apical ballooning) using 99mTc-tetrofosmin, 123I-BMIPP, 123I-MIBG and 99mTc-PYP myocardial SPECT. Ann Nucl Med 19 (2005) 435-445
54. 123I-BMIPP scintigraphy and left ventricular dysfunction in patients with dilated cardiomyopathy. Ann Nucl Med 10 (1996) 225-230
55. 123I-BMIPP-gated SPECT. J Nucl Med 40 (1999) 1840-1847
56. Nakasato M., Ando A., Isobe S., et al. Evaluation of left ventricular function using electrocardiographically gated myocardial SPECT with (123)I-labeled fatty acid analog. J Nucl Med 42 (2001) 1747-1756
57. Yoshinaga K., Tahara M., Torii H., and Kihara K. Predicting the effects on patients with dilated cardiomyopathy of beta-blocker therapy by using iodine-123 15-(p-iodophenyl)-3-R,S-methylpentadecanoic acid (BMIPP) myocardial scintigraphy. Ann Nucl Med 12 (1998) 341-347